Dozens of recent papers review the hundreds of research studies on the growth-promoting role of prostaglandins in cancer growth generally, and specifically the therapeutic benefits of its synthesis inhibition by COX-2 inhibitors such as celecoxib [33,34,35,36]. Here, PTGS2 is linked to cancer.